Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Pelargonium sidoides
A South African plant used by Zulu healers for respiratory infections; clinical trials show significant efficacy for acute bronchitis, sinusitis, and tonsillitis.
Pelargonium sidoides, known as Umckaloabo, is a South African medicinal plant traditionally used by Zulu healers for respiratory infections. Modern clinical evidence supports its efficacy in acute bronchitis, sinusitis, and tonsillitis, attributed to its active compounds including coumarins, gallic acid derivatives, proanthocyanidins, and tannins. It is commonly standardized to the EPs 7630 extract for therapeutic use.
Umckaloabo exerts its effects through multiple mechanisms: it inhibits bacterial adhesion to respiratory epithelial cells, stimulates ciliary beat frequency to enhance mucociliary clearance, and modulates immune responses by increasing natural killer cell activity and macrophage phagocytosis. The active compounds, particularly proanthocyanidins and coumarins, also exhibit antiviral activity by interfering with viral hemagglutination and replication. Additionally, it reduces pro-inflammatory cytokine production (e.g., TNF-α, IL-6) via modulation of NF-κB and TLR4 pathways, contributing to its anti-inflammatory effects.
A South African plant used by Zulu healers for respiratory infections; clinical trials show significant efficacy for acute bronchitis, sinusitis, and tonsillitis.
Pelargonium sidoides, known as Umckaloabo, is a South African medicinal plant traditionally used by Zulu healers for respiratory infections. Modern clinical evidence supports its efficacy in acute bronchitis, sinusitis, and tonsillitis, attributed to its active compounds including coumarins, gallic acid derivatives, proanthocyanidins, and tannins. It is commonly standardized to the EPs 7630 extract for therapeutic use.
Umckaloabo exerts its effects through multiple mechanisms: it inhibits bacterial adhesion to respiratory epithelial cells, stimulates ciliary beat frequency to enhance mucociliary clearance, and modulates immune responses by increasing natural killer cell activity and macrophage phagocytosis. The active compounds, particularly proanthocyanidins and coumarins, also exhibit antiviral activity by interfering with viral hemagglutination and replication. Additionally, it reduces pro-inflammatory cytokine production (e.g., TNF-α, IL-6) via modulation of NF-κB and TLR4 pathways, contributing to its anti-inflammatory effects.